ferric citrate has been researched along with Bone Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iguchi, A; Iino, N; Kazama, JJ; Narita, I; Watanabe, Y; Yamamoto, S; Yoshita, K | 1 |
1 other study(ies) available for ferric citrate and Bone Diseases
Article | Year |
---|---|
Administration of Ferric Citrate Hydrate Decreases Circulating FGF23 Levels Independently of Serum Phosphate Levels in Hemodialysis Patients with Iron Deficiency.
Topics: 25-Hydroxyvitamin D 2; Adult; Aged; Anemia, Iron-Deficiency; Bone Diseases; Chelating Agents; Female; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphates; Prospective Studies; Renal Dialysis; Sevelamer; Young Adult | 2015 |